Calumet (NASDAQ:CLMT) Price Target Raised to $75.00

Calumet (NASDAQ:CLMTFree Report) had its price target lifted by HC Wainwright from $60.00 to $75.00 in a report published on Wednesday morning, MarketBeat.com reports. HC Wainwright currently has a buy rating on the oil and gas company’s stock. HC Wainwright also issued estimates for Calumet’s Q3 2026 earnings at $0.62 EPS, Q4 2026 earnings at $0.24 EPS, FY2026 earnings at $0.17 EPS and FY2027 earnings at $1.11 EPS.

CLMT has been the topic of a number of other research reports. The Goldman Sachs Group raised their price target on Calumet from $40.00 to $45.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 18th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research report on Friday, August 7th. UBS Group increased their target price on Calumet from $26.00 to $47.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 25th. TD Cowen raised their target price on shares of Calumet from $34.00 to $40.00 and gave the stock a “hold” rating in a report on Wednesday, August 12th. Finally, Citigroup reaffirmed a “buy” rating on shares of Calumet in a research note on Monday, August 10th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $51.75.

Read Our Latest Research Report on CLMT

Calumet Stock Down 0.7%

CLMT opened at $53.13 on Wednesday. Calumet has a 12 month low of $16.75 and a 12 month high of $54.69. The company has a fifty day simple moving average of $43.76 and a 200 day simple moving average of $36.21. The stock has a market cap of $4.67 billion, a P/E ratio of -34.28 and a beta of 0.72.

Calumet (NASDAQ:CLMTGet Free Report) last posted its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of $0.07 by ($1.16). The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.12 billion. During the same quarter in the previous year, the company posted ($1.70) EPS. The company’s quarterly revenue was up 40.8% on a year-over-year basis. On average, equities research analysts expect that Calumet will post 0.48 earnings per share for the current fiscal year.

Insider Activity at Calumet

In other news, Director Daniel Sajkowski sold 4,240 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the sale, the director directly owned 77,718 shares in the company, valued at $2,810,282.88. The trade was a 5.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 3.15% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Calumet

Hedge funds and other institutional investors have recently bought and sold shares of the company. Two Seas Capital LP acquired a new position in Calumet during the 2nd quarter worth approximately $238,442,000. California State Teachers Retirement System grew its stake in shares of Calumet by 3,320.8% during the 2nd quarter. California State Teachers Retirement System now owns 2,859,088 shares of the oil and gas company’s stock worth $102,984,000 after acquiring an additional 2,775,509 shares in the last quarter. Bank of America Corp DE acquired a new stake in shares of Calumet in the second quarter valued at approximately $35,348,000. Renaissance Technologies LLC acquired a new stake in shares of Calumet in the first quarter valued at approximately $14,066,000. Finally, Mariner LLC lifted its position in shares of Calumet by 959.6% in the third quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock worth $6,742,000 after purchasing an additional 334,544 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company’s stock.

Calumet News Summary

Here are the key news stories impacting Calumet this week:

  • Positive Sentiment: HC Wainwright raised its earnings forecasts and maintained a Buy rating. The firm increased its Q3 2026 EPS estimate to $0.62 from $0.60, Q4 to $0.24 from $0.22, FY2026 to $0.17 from $0.12, and FY2027 to $1.11 from $0.59. Its $75 price target implies substantial upside from the stock’s recent trading level. HC Wainwright earnings estimate report
  • Positive Sentiment: The upward revisions suggest HC Wainwright expects stronger profitability over the next several quarters, potentially reflecting improved operating performance or business conditions. The revised FY2027 forecast is notably above the broader current-year consensus estimate of $0.46 per share. Calumet stock price expected to rise
  • Neutral Sentiment: Calumet announced plans to attend the H.C. Wainwright conference. The event could provide investors with updates on strategy and operations, but no new financial information was disclosed in the announcement. Calumet conference announcement
  • Neutral Sentiment: A Zacks analysis compared Calumet’s year-to-date performance with TXO Partners and the broader oil-and-energy sector. The article provides relative-performance context but does not indicate a new company-specific catalyst. Zacks Calumet sector performance analysis
  • Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. Although the announcement does not establish wrongdoing, the prospect of litigation or regulatory concerns may weigh on sentiment and introduce uncertainty. Pomerantz investor investigation

Calumet Company Profile

(Get Free Report)

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

Read More

Analyst Recommendations for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.